Page last updated: 2024-08-24

atorvastatin and Atrial Fibrillation

atorvastatin has been researched along with Atrial Fibrillation in 73 studies

Research

Studies (73)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	14 (19.18)	29.6817
2010's	50 (68.49)	24.3611
2020's	9 (12.33)	2.80

Authors

Authors	Studies
Chan, ECY; Soh, XQ; Tan, DS	1
Bongiorno, A; Compagnoni, S; Fasolino, A; Gentile, FR; Oliveri, F; Pepe, A; Tua, L	1
Li, X; Yang, Q; Yang, Y	1
Ali, M; Brandes, A; Dahl, JS; Gerke, O; Krasniqi, L; Mortensen, PE; Riber, LPS	1
Hu, WS; Lin, CL; Yu, TS	1
Bashir, Y; Betts, T; Carnicer, R; Casadei, B; Channon, KM; Crabtree, MJ; DeSilva, R; Goodfellow, N; Hill, M; Jayaram, R; Jones, M; Nahar, K; Pal, N; Petrou, M; Ratnatunga, C; Reilly, S; Roalfe, A; Sayeed, R; Simon, J	1
Bolek, T; Galajda, P; Grilusová, K; Kubisz, P; Mokáň, M; Samoš, M; Škorňová, I; Stančiaková, L; Staško, J	1
Brewer, AC; Bub, G; Carnicer, R; Casadei, B; Mighiu, AS; Recalde, A; Shah, AM; Simon, JN; Tomek, J; Verheule, S; Ziberna, K	1
Bolek, T; Galajda, P; Kubisz, P; Mokáň, M; Samoš, M; Škorňová, I; Stančiaková, L; Staško, J; Vádelová, Ľ	1
Bonsu, KO; Buabeng, KO; Kadirvelu, A; Owusu, IK; Reidpath, DD	1
Carroll, C; Hassanin, A	1
Fernando, T; Kang, Q; Li, X; Wan, Z; Yang, M	1
Hovland, A; Kjellmo, CA; Lappegård, KT; Pop, G	1
Abd-Elshafy, SK; Allah, EA; Elkhayat, H; Elmelegy, TTH; Ibrahim, AS; Kamel, EZ; Minshawy, AA; Nabil, F; Osman, HM	1
Brodowski, K; Jaworski, K; Kosior, DA; Krzykwa, A; Opolski, G; Zylińska, E	1
Abaci, O; Coskun, U; Kilickesmez, KO; Kocas, C; Oktay, V; Yigit, Z; Yildiz, A; Yildiz, CE	1
Lappegård, KT; Pop, G; Pop-Purceleanu, M; Sexton, J; Tendolkar, I; van Heerde, W	1
Akın, F; Avcı, II; Ayça, B; Can, MM; Çelik, Ö; Dinçkal, MH; Okuyan, E; Şahin, I; Yıldız, SS	1
Guo, F; Han, W; Li, JX; Li, YD; Tang, BP; Tang, Q; Zhang, YY	1
Liu, X; Qu, Y; Shen, H; Xia, J	1
Li, Y; Qi, X; Yang, Q	1
Guan, Y; Guo, HY; Shan, ZL; Wang, YT; Yuan, HT; Zhang, Y	1
Dehghani, MR; Kasianzadeh, M; Rezaei, Y; Sepehrvand, N	1
Berg, AH; Drechsler, C; Hod, T; Kalim, S; Karumanchi, SA; Suntharalingam, P; Thadhani, RI; Wanner, C; Wenger, JB	1
Koza, Y; Şenocak, H; Şimşek, Z; Taş, H	1
Ata, Y; Aydın, U; Düzyol, Ç; Koçoğulları, CU; Orhan, AL; Türk, T; Yılmaz, M	1
Ata, Y; Aydýn, U; Türk, T	1
Gu, HY; Jiang, L; Shi, MY; Teng, SC; Xue, FH; Yin, F; Zhu, J	1
Gu, HY; Jiang, L; Li, XD; Shi, MY; Su, FC; Sun, SX; Teng, SC; Xue, FH; Yin, F; Zhu, J	1
Küçüker, A; Kunt, A; Odabaşi, D; Özcan, S; Sami Kunt, A	1
Covassin, N; Friedman, PA; Kara, T; Koestler, C; Lerman, A; Lopez-Jimenez, F; Ruzek, L; Singh, P; Somers, VK; Soucek, F; Suleiman, M	1
Çakır, H; İşcan, Ş; Kestelli, M; Peker, İ; Yürekli, İ	1
Ata, Y; Aydın, U; Türk, T	1
Dang, Y; Hao, X; Qi, X; Song, X; Yang, Q	1
Brugia, M; Capestro, F; Crescenzi, G; D'Alfonso, A; Pierri, MD; Scocco, V; Torracca, L; Zingaro, C	1
Dang, Y; Hao, X; Li, Y; Qi, X; Song, X; Yang, Q	1
Hong, JM; Lee, JS; Lim, SG; Park, RW; Shin, D; Yoon, D	1
Cui, W; Xie, R; Yang, Y; Yin, H; You, L; Zhang, J; Zheng, H	1
Chiang, FT; Hwang, JJ; Lai, LP; Lin, JL; Tsai, CT; Wang, YC	1
Kim, JH; Kim, JS; Kim, WS; Lee, SH; Lee, YT; On, YK; Shin, DH; Song, YB; Sung, J	1
Almroth, H; Boman, K; Englund, A; Höglund, N; Jensen, S; Kjellman, B; Rosenqvist, M; Tornvall, P	1
Kanic, V; Naji, F; Sabovic, M; Suran, D; Vokac, D	1
Cai, J; Chi, L; Feng, J; Ji, Q; Mei, Y; Sun, Y; Wang, X; Xie, S	1
Cai, JZ; Feng, J; Ji, Q; Mei, YQ; Sun, YF; Wang, XS; Xie, SL; Zhou, YX	1
Aronow, WS; Banach, M; Bielecka-Dabrowa, A; Desai, R; Goch, JH; Maciejewski, M; Rysz, J	1
Arai, H; Ito, F; Miyagi, N; Someya, T; Tamura, K; Ushiyama, T	1
Abuladze, GV; Dundua, GI; Dzhindzholiia, NR; Nebieridze, MI	1
Camm, J; Hosseini, MT; Jahangiri, M; Kourliouros, A; Mayr, M; Sarsam, M; Valencia, O	1
Bentz, K; Eick, C; Kettering, K; Laszlo, R; Menzel, KA; Schreieck, J; Schreiner, B	1
Takagi, H; Umemoto, T	1
Bloom, HL; Dudley, SC; Jones, DP; Negi, S; Shukrullah, I; Veledar, E	1
Kuo, CD	1
Almroth, H; Andersson, J; Boman, K; Englund, A; Höglund, N; Jensen, S; Rosenqvist, M; Tornvall, P	1
Bouwels, L; de Leeuw, FE; Enajat, M; Pop, G; Pop-Purceleanu, M; Tendolkar, I; van Kuilenburg, J; van Wingen, G; Zwiers, MP	1
Cai, J; Chi, L; Feng, J; Ji, Q; Mei, Y; Sun, Y; Wang, X	1
Chaitman, BR; Goldberger, JJ; Messig, M; Schwartz, GG	1
Akilli, H; Alihanoglu, Y; Altunkeser, BB; Aribas, A; Ayhan, S; Can, I; Demir, K; Koc, F; Vatankulu, MA	1
Asirvatham, SJ; Bradley, D; Brady, PA; Cha, YM; Friedman, PA; Herges, R; Hodge, D; Koestler, C; Lerman, A; Lopez-Jimenez, F; Munger, TM; Packer, DL; Suleiman, M	1
Goette, A	1
Komatsu, T; Kunugita, F; Nakamura, M; Ozawa, M; Sato, Y; Tachibana, H	1
Bidhendi, LM; Bina, P; Fathollahi, MS; Karimi, A; Molai, M; Rezvanfard, M; Sadeghian, S; Yousefi, A; Zare, E	1
Fenech, ME; Mackay, JW; Myint, KS	1
Almroth, H; Andersson, J; Boman, K; Englund, A; Höglund, N; Jensen, SM; Rosenqvist, M; Tornvall, P	1
Creswell, LL	1
Bang, CN; Gislason, GH; Greve, AM; Køber, L; Torp-Pedersen, C; Wachtell, K	1
Dernellis, J; Panaretou, M	1
Altinbas, A; Aslan, SM; Dogan, A; Kucuktepe, Z; Ozaydin, M; Ozturk, M; Varol, E	1
Candura, D; Chello, M; Covino, E; D'Ambrosio, A; Di Sciascio, G; Pasceri, V; Patti, G	1
García-Fernández, A; Mainar, L; Marín, F; Martínez, JG; Roldán, V	1
Hawkins, NM; MacDonald, MR; Padfield, GJ	1
Orlandi, QG; Shroff, GR	1
Blazing, M; Cannon, CP; Gersh, B; McLean, DS; Ravid, S; Shui, A	1
Camm, J; De Souza, A; Jahangiri, M; Kourliouros, A; Marciniak, A; Roberts, N; Tsiouris, A; Valencia, O	1

Reviews

5 review(s) available for atorvastatin and Atrial Fibrillation

Article	Year
Statin and Postcardiac Surgery Atrial Fibrillation Prevention: A Systematic Review and Meta-Analysis. Journal of cardiovascular pharmacology, 2022, 08-01, Volume: 80, Issue:2 Topics: Atorvastatin; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Complications; Rosuvastatin Calcium	2022
The preventive effect of atorvastatin on atrial fibrillation: a meta-analysis of randomized controlled trials. BMC cardiovascular disorders, 2014, Aug-13, Volume: 14 Topics: Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Chi-Square Distribution; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Odds Ratio; Primary Prevention; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Secondary Prevention; Treatment Outcome	2014
Effect of Atorvastatin on Serum Levels of Total Cholesterol and High-Sensitivity C-reactive Protein in High-Risk Patients with Atrial Fibrillation in Asia. Clinical therapeutics, 2015, Volume: 37, Issue:8 Topics: Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Cholesterol; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Treatment Outcome	2015
Atorvastatin Treatment for Atrial Fibrillation Reduces Serum High-Sensitivity C-Reactive Protein Levels. BioMed research international, 2015, Volume: 2015 Topics: Adult; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Case-Control Studies; Female; Humans; Male; Middle Aged; Odds Ratio; Publication Bias	2015
[Impact of statin therapy on recurrence of persistent atrial fibrillation after electrical cardioversion: a meta-analysis]. Zhonghua xin xue guan bing za zhi, 2015, Volume: 43, Issue:11 Topics: Atorvastatin; Atrial Fibrillation; Electric Countershock; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Randomized Controlled Trials as Topic; Recurrence	2015

Trials

30 trial(s) available for atorvastatin and Atrial Fibrillation

Article	Year
Atorvastatin and the influence on postoperative atrial fibrillation after surgical aortic valve replacement (STARC) in adults at Odense University Hospital, Denmark: study protocol for a randomised controlled trial. BMJ open, 2023, 05-10, Volume: 13, Issue:5 Topics: Adult; Aortic Valve; Atorvastatin; Atrial Fibrillation; Denmark; Hospitals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Complications; Prospective Studies; Randomized Controlled Trials as Topic	2023
Atrial nitroso-redox balance and refractoriness following on-pump cardiac surgery: a randomized trial of atorvastatin. Cardiovascular research, 2022, 01-07, Volume: 118, Issue:1 Topics: Action Potentials; Atorvastatin; Atrial Fibrillation; Atrial Function, Right; Biopterins; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Double-Blind Method; England; Heart Atria; Heart Rate; Humans; NADPH Oxidases; Nitric Oxide Synthase; Nitroso Compounds; Oxidation-Reduction; Refractory Period, Electrophysiological; Superoxides; Time Factors; Treatment Outcome	2022
Intensive lipid lowering therapy reduces large, but not small, dense low-density lipoprotein particles measured by gel electrophoresis, in elderly patients with atrial fibrillation. European journal of preventive cardiology, 2019, Volume: 26, Issue:18 Topics: Age Factors; Aged; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; Cholesterol, LDL; Cholesterol, VLDL; Electrophoresis; Humans; Hypercholesterolemia	2019
Could Short-Term Perioperative High-Dose Atorvastatin Offer Antiarrhythmic and Cardio-Protective Effects in Rheumatic Valve Replacement Surgery? Journal of cardiothoracic and vascular anesthesia, 2019, Volume: 33, Issue:12 Topics: Adolescent; Adult; Atorvastatin; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Egypt; Female; Follow-Up Studies; Heart Valve Prosthesis Implantation; Heart Valves; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Perioperative Care; Postoperative Complications; Prospective Studies; Rheumatic Heart Disease; Treatment Outcome; Young Adult	2019
Patients with stable coronary artery disease receiving chronic statin treatment who are undergoing noncardiac emergency surgery benefit from acute atorvastatin reload. Cardiology, 2014, Volume: 128, Issue:3 Topics: Aged; Atorvastatin; Atrial Fibrillation; Coronary Artery Disease; Death, Sudden, Cardiac; Disease-Free Survival; Double-Blind Method; Emergency Treatment; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Myocardial Infarction; Postoperative Complications; Preoperative Care; Prospective Studies; Pyrroles; Treatment Outcome	2014
Atorvastatin Reduces the Incidence of Postoperative Atrial Fibrillation in Statin-Naive Patients Undergoing Isolated Heart Valve Surgery: A Double-Blind, Placebo-Controlled Randomized Trial. Journal of cardiovascular pharmacology and therapeutics, 2015, Volume: 20, Issue:5 Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; Cardiac Surgical Procedures; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Valve Diseases; Humans; Iran; Kaplan-Meier Estimate; Male; Middle Aged; Perioperative Care; Placebos	2015
Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease. Kidney international, 2015, Volume: 87, Issue:6 Topics: Aged; Atorvastatin; Atrial Fibrillation; Cause of Death; Cholesterol; Comorbidity; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Renal Dialysis; Risk Factors; Serum Albumin; Survival Rate; Troponin T; Uremia	2015
Efficiency of postoperative statin treatment for preventing new-onset postoperative atrial fibrillation in patients undergoing isolated coronary artery bypass grafting: A prospective randomized study. Anatolian journal of cardiology, 2015, Volume: 15, Issue:6 Topics: Aged; Atorvastatin; Atrial Fibrillation; Coronary Artery Bypass; Echocardiography; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Middle Aged; Postmenopause; Postoperative Complications; Prospective Studies; Treatment Outcome	2015
Effects of perioperative statin treatment on postoperative atrial fibrillation and cardiac mortality in patients undergoing coronary artery bypass grafting: a propensity score analysis. Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina, 2015, Volume: 12, Issue:2 Topics: Aged; Atorvastatin; Atrial Fibrillation; Coronary Artery Bypass; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Perioperative Care; Postoperative Complications; Propensity Score; Retrospective Studies	2015
Effects of Atorvastatin (80 mg) Therapy on Quantity of Epicardial Adipose Tissue in Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation. The American journal of cardiology, 2015, Nov-01, Volume: 116, Issue:9 Topics: Adipose Tissue; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; Biomarkers; Body Mass Index; C-Reactive Protein; Cholesterol, LDL; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pericardium; Predictive Value of Tests; Prospective Studies; Pulmonary Veins; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome	2015
Prevention of atrial fibrillation and inflammatory response after on-pump coronary artery bypass using different statin dosages: a randomized, controlled trial. General thoracic and cardiovascular surgery, 2016, Volume: 64, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Artery Bypass; Dose-Response Relationship, Drug; Drug Administration Schedule; Elective Surgical Procedures; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Inflammation; Interleukin-6; Male; Middle Aged; Postoperative Complications; Preoperative Care; Prospective Studies; Treatment Outcome	2016
Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: a prospective randomized trial. American heart journal, 2008, Volume: 156, Issue:1 Topics: Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; Bradycardia; Cardiac Pacing, Artificial; Combined Modality Therapy; Confidence Intervals; Echocardiography, Doppler; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Pacemaker, Artificial; Probability; Proportional Hazards Models; Prospective Studies; Pyrroles; Reference Values; Risk Assessment; Survival Analysis; Treatment Outcome	2008
The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. American heart journal, 2008, Volume: 156, Issue:2 Topics: Aged; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Coronary Artery Bypass, Off-Pump; Elective Surgical Procedures; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Peptide Fragments; Postoperative Complications; Premedication; Prospective Studies; Pyrroles	2008
Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study. European heart journal, 2009, Volume: 30, Issue:7 Topics: Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Double-Blind Method; Electric Countershock; Female; Heptanoic Acids; Humans; Male; Prospective Studies; Pyrroles; Secondary Prevention; Sweden; Treatment Outcome	2009
Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. Circulation journal : official journal of the Japanese Circulation Society, 2009, Volume: 73, Issue:12 Topics: Administration, Oral; Aged; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Artery Bypass, Off-Pump; Double-Blind Method; Drug Administration Schedule; Elective Surgical Procedures; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Odds Ratio; Preoperative Care; Pyrroles; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2009
[Effect of atorvastatin on postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting]. Zhonghua yi xue za zhi, 2009, Nov-17, Volume: 89, Issue:42 Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Coronary Artery Bypass; Coronary Artery Disease; Female; Heptanoic Acids; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pyrroles; Risk Factors	2009
Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study. Lipids in health and disease, 2010, Feb-23, Volume: 9 Topics: Adult; Aged; Atorvastatin; Atrial Fibrillation; Body Mass Index; Cardiomyopathy, Dilated; Echocardiography; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-10; Interleukin-6; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Prospective Studies; Pyrroles; Tumor Necrosis Factor-alpha	2010
Preoperative high-dose atorvastatin for prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. The Journal of thoracic and cardiovascular surgery, 2011, Volume: 141, Issue:1 Topics: Aged; Atorvastatin; Atrial Fibrillation; Chi-Square Distribution; Coronary Artery Bypass; Drug Administration Schedule; Female; Heart Valve Prosthesis Implantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; London; Male; Middle Aged; Preoperative Care; Prospective Studies; Pyrroles; Regression Analysis; Risk Assessment; Risk Factors; Single-Blind Method; Time Factors; Treatment Outcome	2011
Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial). Journal of cardiovascular electrophysiology, 2011, Volume: 22, Issue:4 Topics: Aged; Atorvastatin; Atrial Fibrillation; Biomarkers; Double-Blind Method; Electric Countershock; Female; Follow-Up Studies; Heptanoic Acids; Humans; Inflammation Mediators; Male; Middle Aged; Oxidative Stress; Pyrroles; Treatment Outcome	2011
Markers of fibrinolysis as predictors for maintenance of sinus rhythm after electrical cardioversion. Thrombosis research, 2011, Volume: 127, Issue:3 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Electric Countershock; Female; Fibrinolysis; Heptanoic Acids; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Pyrroles; Recurrence; Tissue Plasminogen Activator	2011
One-year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke-free elderly with atrial fibrillation: evidence from a parallel group randomized trial. International journal of geriatric psychiatry, 2012, Volume: 27, Issue:1 Topics: Aged; Aged, 80 and over; Analysis of Variance; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; Atrophy; Azetidines; Biomarkers; Cholesterol; Double-Blind Method; Ezetimibe; Female; Heptanoic Acids; Humans; Male; Memory; Memory Disorders; Neuropsychological Tests; Pyrroles; Temporal Lobe	2012
Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting. International heart journal, 2011, Volume: 52, Issue:1 Topics: Aged; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Artery Bypass; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Postoperative Period; Preoperative Period; Pyrroles; Treatment Outcome	2011
High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. American heart journal, 2011, Volume: 161, Issue:5 Topics: Atorvastatin; Atrial Fibrillation; Cholesterol; Chronic Disease; Disease Progression; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Ischemic Attack, Transient; Male; Middle Aged; Pyrroles; Retrospective Studies; Stroke; Survival Rate; Time Factors; Treatment Outcome	2011
Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy. Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2011, Volume: 20, Issue:5 Topics: Analysis of Variance; Anti-Arrhythmia Agents; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Chronic Disease; Electric Countershock; Female; Fibrinogen; Health Status Indicators; Heptanoic Acids; Humans; Leukocyte Count; Male; Middle Aged; Pyrroles; Secondary Prevention; Time Factors; Warfarin	2011
Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial. Heart rhythm, 2012, Volume: 9, Issue:2 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; Catheter Ablation; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Postoperative Complications; Pulmonary Veins; Pyrroles; Quality of Life; Secondary Prevention; Treatment Outcome	2012
The predictive value of C-reactive protein on recurrence of atrial fibrillation after cardioversion with or without treatment with atorvastatin. International journal of cardiology, 2013, Sep-01, Volume: 167, Issue:5 Topics: Aged; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Double-Blind Method; Electric Countershock; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyrroles; Recurrence; Treatment Outcome	2013
Effect of C-reactive protein reduction on paroxysmal atrial fibrillation. American heart journal, 2005, Volume: 150, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Female; Heptanoic Acids; Humans; Male; Middle Aged; Pyrroles	2005
Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion. The American journal of cardiology, 2006, May-15, Volume: 97, Issue:10 Topics: Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Body Mass Index; C-Reactive Protein; Electric Countershock; Female; Heptanoic Acids; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pyrroles; Recurrence; Risk Factors; Treatment Outcome	2006
Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation, 2006, Oct-03, Volume: 114, Issue:14 Topics: Aged; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Cardiac Surgical Procedures; Cerebrovascular Disorders; Female; Heart Diseases; Heptanoic Acids; Humans; Length of Stay; Male; Middle Aged; Postoperative Complications; Pyrroles	2006
Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials. American heart journal, 2008, Volume: 155, Issue:2 Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Atorvastatin; Atrial Fibrillation; Dose-Response Relationship, Drug; Fibrinolytic Agents; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Pravastatin; Pyrroles; Thrombolytic Therapy; Tirofiban; Tyrosine	2008

Other Studies

38 other study(ies) available for atorvastatin and Atrial Fibrillation

Article	Year
Simvastatin, but Not Atorvastatin, Is Associated with Higher Peak Rivaroxaban Serum Levels and Bleeding: an Asian Cohort Study from Singapore. Cardiovascular drugs and therapy, 2023, Volume: 37, Issue:5 Topics: Anticoagulants; Asian People; Atorvastatin; Atrial Fibrillation; Cohort Studies; Dabigatran; Drug Therapy, Combination; Hemorrhage; Humans; Rivaroxaban; Simvastatin; Singapore; Stroke	2023
Related Factors of Cerebral Hemorrhage after Cerebral Infarction and the Effect of Atorvastatin Combined with Intensive Nursing Care. Computational and mathematical methods in medicine, 2022, Volume: 2022 Topics: Adult; Atorvastatin; Atrial Fibrillation; Case-Control Studies; Cerebral Hemorrhage; Cerebral Infarction; Humans; Hypertension; Retrospective Studies; Stroke; Tablets	2022
Statin versus ezetimibe-statin for incident atrial fibrillation among patients with type 2 diabetes mellitus with acute coronary syndrome and acute ischemic stroke. Medicine, 2023, Jun-09, Volume: 102, Issue:23 Topics: Acute Coronary Syndrome; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; Diabetes Mellitus, Type 2; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Stroke; Simvastatin; Stroke; Treatment Outcome	2023
The impact of atorvastatin on dabigatran plasma levels in patients with atrial fibrillation. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2021, 01-01, Volume: 32, Issue:1 Topics: Aged; Anticholesteremic Agents; Antithrombins; Atorvastatin; Atrial Fibrillation; Dabigatran; Female; Humans; Male; Pilot Projects	2021
Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice. Cardiovascular research, 2021, 09-28, Volume: 117, Issue:11 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Disease Models, Animal; Enzyme Induction; Enzyme Inhibitors; Heart Atria; Heart Rate; Mice, Transgenic; Myocytes, Cardiac; NADPH Oxidase 2; Signal Transduction; Superoxides; Time Factors	2021
Does atorvastatin therapy change the anti-Xa activity in xabans-treated patients with atrial fibrillation? Pharmacology research & perspectives, 2021, Volume: 9, Issue:3 Topics: Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; Drug Interactions; Factor Xa Inhibitors; Female; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thrombosis	2021
Statin Treatment and Clinical Outcomes of Heart Failure Among Africans: An Inverse Probability Treatment Weighted Analysis. Journal of the American Heart Association, 2017, Apr-01, Volume: 6, Issue:4 Topics: Aged; Atorvastatin; Atrial Fibrillation; Black People; Cardiomyopathy, Dilated; Cardiovascular Diseases; Cause of Death; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Fatty Acids, Monounsaturated; Fluvastatin; Ghana; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Indoles; Kaplan-Meier Estimate; Longitudinal Studies; Middle Aged; Mortality; Multivariate Analysis; Probability; Proportional Hazards Models; Renal Insufficiency, Chronic; Retrospective Studies; Rosuvastatin Calcium; Simvastatin; Treatment Outcome	2017
Polypharmacy in the Elderly-When Good Drugs Lead to Bad Outcomes: A Teachable Moment. JAMA internal medicine, 2017, 06-01, Volume: 177, Issue:6 Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Antihypertensive Agents; Atorvastatin; Atrial Fibrillation; Bone Density Conservation Agents; Deprescriptions; Digoxin; Diltiazem; Diuretics; Drug Overdose; Factor Xa Inhibitors; Female; Furosemide; Heart Failure; Histamine H1 Antagonists, Non-Sedating; Histamine H2 Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ibandronic Acid; Lisinopril; Loratadine; Metoprolol; Polypharmacy; Pyrazoles; Pyridones; Ranitidine; Syncope	2017
Galectin-3 in patients with coronary heart disease and atrial fibrillation. Clinica chimica acta; international journal of clinical chemistry, 2018, Volume: 478 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; Blood Proteins; Catheter Ablation; Coronary Disease; Female; Fibrosis; Galectin 3; Galectins; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Severity of Illness Index; Stroke Volume	2018
[Role of inflammation in etiology of atrial fibrillation--is lone arrhythmia really alone]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2012, Volume: 65, Issue:4 Topics: Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Pyrroles; Recurrence	2012
Comparison of rosuvastatin versus atorvastatin for preventing postoperative atrial fibrillation. The heart surgery forum, 2013, Volume: 16, Issue:3 Topics: Atorvastatin; Atrial Fibrillation; Comorbidity; Coronary Artery Bypass; Coronary Artery Disease; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Premedication; Prevalence; Pyrimidines; Pyrroles; Retrospective Studies; Risk Assessment; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Turkey	2013
Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy. Journal of neuroinflammation, 2013, Jun-28, Volume: 10 Topics: Aged; Amygdala; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; Azetidines; Brain; Cognition; Electrocardiography; Executive Function; Ezetimibe; Female; Heptanoic Acids; Hippocampus; Humans; Image Processing, Computer-Assisted; Inflammation; Magnetic Resonance Imaging; Male; Memory; Neuroimaging; Neuropsychological Tests; Psychomotor Performance; Pyrroles; Reaction Time; Vocabulary	2013
The effect of atorvastatin on P wave dispersion in hyperlipidemic patients. Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina, 2013, Volume: 10, Issue:2 Topics: Atorvastatin; Atrial Fibrillation; Electrocardiography; Humans	2013
Effect of atorvastatin on left atrial function of patients with paroxysmal atrial fibrillation. Genetics and molecular research : GMR, 2013, Sep-10, Volume: 12, Issue:3 Topics: Adult; Atorvastatin; Atrial Fibrillation; Atrial Function, Left; Echocardiography; Female; Heart Atria; Heptanoic Acids; Humans; Hypertension; Male; Middle Aged; Pyrroles	2013
Role of inflammation in the initiation and maintenance of atrial fibrillation and the protective effect of atorvastatin in a goat model of aseptic pericarditis. Molecular medicine reports, 2015, Volume: 11, Issue:4 Topics: Animals; Atorvastatin; Atrial Fibrillation; Cardiac Surgical Procedures; Cytokines; Disease Models, Animal; Goats; Heart Atria; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Male; Pericarditis; Pyrroles	2015
Trial design, statins, atrial fibrillation, and prevention: four horsemen of the apocalypse. Anatolian journal of cardiology, 2015, Volume: 15, Issue:4 Topics: Atorvastatin; Atrial Fibrillation; Coronary Artery Bypass; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Complications	2015
Trial design, statins, atrial fibrillation, and prevention: four horsemen of the apocalypse--author's reply. Anatolian journal of cardiology, 2015, Volume: 15, Issue:4 Topics: Atorvastatin; Atrial Fibrillation; Coronary Artery Bypass; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Complications	2015
Atrial fibrillation after cardiac surgery. Anatolian journal of cardiology, 2015, Volume: 15, Issue:10 Topics: Atorvastatin; Atrial Fibrillation; Coronary Artery Bypass; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Complications	2015
Author's Reply. Anatolian journal of cardiology, 2015, Volume: 15, Issue:10 Topics: Atorvastatin; Atrial Fibrillation; Coronary Artery Bypass; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Complications	2015
Effects of atorvastatin on atrial remodeling in a rabbit model of atrial fibrillation produced by rapid atrial pacing. BMC cardiovascular disorders, 2016, 06-24, Volume: 16, Issue:1 Topics: Animals; Atorvastatin; Atrial Fibrillation; Atrial Function, Right; Atrial Remodeling; Blotting, Western; Cardiac Pacing, Artificial; Disease Models, Animal; DNA; Echocardiography; Electrocardiography; Heart Atria; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Peroxidase; Rabbits; Real-Time Polymerase Chain Reaction	2016
Comparison of the Risk of Gastrointestinal Bleeding among Different Statin Exposures with Concomitant Administration of Warfarin: Electronic Health Record-Based Retrospective Cohort Study. PloS one, 2016, Volume: 11, Issue:7 Topics: Aged; Anticoagulants; Atorvastatin; Atrial Fibrillation; Drug Interactions; Electronic Health Records; Female; Gastrointestinal Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Pravastatin; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rosuvastatin Calcium; Simvastatin; Software; Tertiary Care Centers; Warfarin	2016
Atorvastatin can ameliorate left atrial stunning induced by radiofrequency ablation for atrial fibrillation. Canadian journal of physiology and pharmacology, 2017, Volume: 95, Issue:9 Topics: Adult; Aged; Atorvastatin; Atrial Fibrillation; Catheter Ablation; Female; Heart Atria; Humans; Male; Middle Aged; Myocardial Stunning; Stroke Volume; Systole	2017
Comparison of atorvastatin and simvastatin in prevention of atrial fibrillation after successful cardioversion. International heart journal, 2009, Volume: 50, Issue:2 Topics: Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Electric Countershock; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Logistic Models; Male; Middle Aged; Odds Ratio; Pyrroles; Retrospective Studies; Simvastatin; Treatment Outcome	2009
Pravastatin treatment before coronary artery bypass grafting for reduction of postoperative atrial fibrillation. General thoracic and cardiovascular surgery, 2010, Volume: 58, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Artery Bypass; Disease-Free Survival; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Pravastatin; Proportional Hazards Models; Pyrroles; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2010
[The efficasy of atorvastatin in the case of paroxismal atrial fibrillation in patients with ischemic heart disease]. Georgian medical news, 2010, Issue:180 Topics: Adult; Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Pyrroles; Treatment Outcome	2010
Atorvastatin treatment affects atrial ion currents and their tachycardia-induced remodeling in rabbits. Life sciences, 2010, Oct-09, Volume: 87, Issue:15-16 Topics: Animals; Atorvastatin; Atrial Fibrillation; Female; Heart Atria; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Ion Channels; Oxidative Stress; Patch-Clamp Techniques; Pyrroles; Rabbits; Tachycardia; Time Factors	2010
Effect of preoperative statin therapy on postoperative atrial fibrillation in cardiac surgery. Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:12 Topics: Administration, Oral; Aged; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Artery Bypass, Off-Pump; Double-Blind Method; Drug Administration Schedule; Elective Surgical Procedures; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Odds Ratio; Preoperative Care; Pyrroles; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2010
Statins, inflammation, oxidative stress, and atrial fibrillation. Journal of cardiovascular electrophysiology, 2011, Volume: 22, Issue:4 Topics: Atorvastatin; Atrial Fibrillation; Female; Heptanoic Acids; Humans; Male; Pyrroles	2011
Neutral effects of statins to prevent atrial fibrillation recurrences after catheter ablation of atrial fibrillation: should we bury upstream therapy for secondary prevention of atrial fibrillation? Heart rhythm, 2012, Volume: 9, Issue:2 Topics: Atorvastatin; Atrial Fibrillation; Catheter Ablation; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Postoperative Complications; Pulmonary Veins; Pyrroles	2012
Long-term efficacy of upstream therapy with lipophilic or hydrophilic statins on antiarrhythmic drugs in patients with paroxysmal atrial fibrillation: comparison between atorvastatin and pravastatin. International heart journal, 2011, Volume: 52, Issue:6 Topics: Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pravastatin; Pyrroles; Retrospective Studies; Secondary Prevention; Tachycardia, Paroxysmal; Time Factors; Treatment Outcome	2011
The effect of a high dose of atorvastatin on the occurrence of atrial fibrillation after coronary artery bypass grafting. The Annals of thoracic surgery, 2012, Volume: 94, Issue:1 Topics: Aged; Atorvastatin; Atrial Fibrillation; Coronary Artery Bypass; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Logistic Models; Male; Middle Aged; Postoperative Complications; Pyrroles; Retrospective Studies	2012
Acute rhabdomyolysis caused by combination therapy with atorvastatin and warfarin. British journal of hospital medicine (London, England : 2005), 2012, Volume: 73, Issue:2 Topics: Acute Disease; Aged; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; Drug Interactions; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Pyrroles; Rhabdomyolysis; Warfarin	2012
Invited commentary. The Annals of thoracic surgery, 2012, Volume: 94, Issue:1 Topics: Atorvastatin; Atrial Fibrillation; Coronary Artery Bypass; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Postoperative Complications; Pyrroles	2012
Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study. European journal of preventive cardiology, 2014, Volume: 21, Issue:3 Topics: Age Factors; Aged; Aged, 80 and over; Atorvastatin; Atrial Fibrillation; Chi-Square Distribution; Comorbidity; Denmark; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Myocardial Infarction; Polypharmacy; Pravastatin; Propensity Score; Proportional Hazards Models; Pyrroles; Registries; Retrospective Studies; Risk Factors; Sex Factors; Simvastatin; Time Factors; Treatment Outcome	2014
Effect of statins on preventing recurrence of atrial fibrillation after electrical cardioversion. The American journal of cardiology, 2006, Nov-01, Volume: 98, Issue:9 Topics: Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Combined Modality Therapy; Electric Countershock; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Secondary Prevention	2006
Letter by Padfield et al regarding article, "Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After Ca Circulation, 2007, Apr-17, Volume: 115, Issue:15 Topics: Atorvastatin; Atrial Fibrillation; Cardiac Surgical Procedures; Confounding Factors, Epidemiologic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Complications; Pyrroles; Randomized Controlled Trials as Topic; Research Design	2007
Letter by Shroff and Orlandi regarding article, "Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia Afte Circulation, 2007, Apr-17, Volume: 115, Issue:15 Topics: Atorvastatin; Atrial Fibrillation; Cardiac Surgical Procedures; Confounding Factors, Epidemiologic; Coronary Artery Bypass; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Complications; Pyrroles; Randomized Controlled Trials as Topic; Research Design	2007
Dose-related effect of statins on atrial fibrillation after cardiac surgery. The Annals of thoracic surgery, 2008, Volume: 85, Issue:5 Topics: Aged; Aged, 80 and over; Aortic Valve; Atorvastatin; Atrial Fibrillation; Cohort Studies; Coronary Artery Bypass; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Heart Valve Prosthesis Implantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Postoperative Complications; Pyrroles; Retrospective Studies; Risk Factors; Simvastatin; Treatment Outcome	2008